Canadian Manufacturing

JUNE 21, 2024

(Credit: GlobeNewswire) EDMONTON — Construction is set to begin on a pharmaceutical manufacturing facility in the Edmonton Research Park that will provide Canadians with a supply of drugs. Construction for the CMPC is set to be completed by 2026. Investment includes $80.5 million in federal funding through PrairiesCan, $17.6

Pharmaceutical 103

Pharmaceutical Supply Chain Manufacturing 103

Manufacturer's Monthly

APRIL 27, 2025

The SMART CRC involves 63 partners spanning government, industry, medical providers, universities and research institutes, all focused on helping Australian biotechnology and pharmaceutical companies bring a 10-year pipeline of regenerative therapy projects to market.

3D printing 98

3D printing Additive manufacturing Pharmaceutical Supply Chain 98

Canadian Manufacturing

AUGUST 29, 2024

“Our life sciences and pharmaceutical capabilities are in demand and helping improve health outcomes in the communities we serve,” commented Ian L. .” The new spaces are expected to be operational by late 2026. MONTREAL — AtkinsRéalis Group Inc.,

Pharmaceutical 52

Pharmaceutical Manufacturing Supply Chain Form 52

Control Engineering

FEBRUARY 2, 2023

Machinery sectors have performed better than the manufacturing sector overall, and despite current challenges the next global downturn for manufacturing is not expected until late 2025 or early 2026. The next manufacturing downturn is expected in 2026, but to a lesser extent than in 2020. in 2022, compared to 3.3% for Europe.

Manufacturing 52

Manufacturing Supply Chain Value chain Pharmaceutical 52

Canadian Manufacturing

FEBRUARY 26, 2024

MONTREAL — Last Fall, Pharmascience, a pharmaceutical company, announced a major $120 million sterile injectable manufacturing facility expansion at its Candiac site. Pharmascience hopes that by 2026, the company will have invested over $120 million to expand its facilities and more than triple its capacity with new equipment.

Pharmaceutical 52

Pharmaceutical Manufacturing Supply Chain 52

Canadian Manufacturing

JANUARY 8, 2025

BARRIE MediPharm Labs announced a commercial agreement with Laboratrio Teuto, a pharmaceutical manufacturer and marketer in Brazil. Brazil’s medical cannabis market includes regulatory requirements such as: ANVISA onsite GMP Inspections: Ensuring adherence to certain pharmaceutical standards.

Pharmaceutical 40

Pharmaceutical Manufacturing Supply Chain 40

Fabricating & Metal Work

OCTOBER 2, 2023

Replacing the existing robotics facilities at the site, the new Campus is planned to open in late 2026. The investment in our new Campus is driven by customer demand and projected market growth,” said Björn Rosengren, ABB CEO. Following important investments in China and the U.S,

Robotics 52

Robotics Robotics Automation Pharmaceutical 52